Going forward, we may see more instances in which insurers deny or (temporarily) severely restrict coverage of accelerated ...
Genentech Inc. won regulatory approval Tuesday to market an eye implant that can be refilled every six months with an already ...
Lately, one of America's leading pharmaceutical companies can't catch a break from Wall Street. Shares of Vertex ...
The approval Journey Medical received from FDA for Emrosi makes DERM an exciting stock. Click here to read more.
The Food and Drug Administration on Thursday approved a new type of nonopioid painkiller from Vertex Pharmaceuticals, NBC ...
The FDA approved a pain drug designed to eliminate the risks associated with opioids -- the first new pharmaceutical approach ...
Amid the uproar over the firing of 18 inspectors general, a report offering a coda to the aducanumab approval episode has ...
1d
stockhead on MSNBiocurious: EBR Systems is on a ‘glide path’ to FDA approval for its novel heart deviceEBR Systems is super confident the US medical gatekeeper will approve Wise, the world's first wireless pacemaker device.
Trump's pick for HHS secretary who endured confirmation hearings last week—has repeatedly criticized industry ties to the FDA ...
RenovoRx's innovative RenovoCath and TAMP platform show promising clinical data. Click here to read why RNXT stock presents ...
The FDA's approval process for Journavx included an evaluation of its safety and efficacy. Clinical trials demonstrated that the drug is effective in managing acute pain without the adverse ...
The STAY study aims to change this reality. Researchers hope that the new drug will slow down the ageing process, improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results